Jounce Therapeutics Inc (JNCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Sales | 0 | 25,368 | 1,539 | 0 | 0 |
| Gross Profit | N/A | 25,368 | 1,539 | N/A | N/A |
| Operating Expenses | 30,142 | 29,417 | 28,122 | 26,918 | 25,104 |
| Operating Income | -30,142 | -4,049 | -26,583 | 35,421 | -25,104 |
| Other Income | 55 | 40 | 49 | 51 | 203 |
| Pre-tax Income | -30,087 | -4,009 | -26,534 | 35,472 | -24,901 |
| Income Tax | 6 | 2 | 1 | 0 | 2 |
| Net Income Continuous | -30,093 | -4,011 | -26,535 | 35,472 | -24,903 |
| Net Income | $-30,093 | $-4,011 | $-26,535 | $35,472 | $-24,903 |
| EPS Basic Total Ops | -0.59 | -0.08 | -0.58 | 1.09 | -0.73 |
| EPS Basic Continuous Ops | -0.59 | -0.08 | -0.58 | 1.09 | -0.73 |
| EPS Diluted Total Ops | -0.59 | -0.08 | -0.58 | 1.09 | -0.73 |
| EPS Diluted Continuous Ops | -0.59 | -0.08 | -0.58 | 1.09 | -0.73 |
| EPS Diluted Before Non-Recurring Items | -0.59 | -0.08 | N/A | N/A | N/A |
| EBITDA(a) | $-29,193 | $-3,134 | $-25,659 | $-26,003 | $-24,271 |